Bolstering Our Ability To Value Health Technology: A Few Less-Considered Issues
AcademyHealth’s Michael E. Gluck authors the next in the IVI and Health Affairs blog series. He describes historical public efforts to implement HTA and how it “intersects with all of the major challenges facing US [...]
Fair Prices Should Lead To Fair Access: Why Is The Grand Bargain So Hard?
In a new post in our ongoing blog series with Health Affairs, ICER's Sarah Emond discusses the challenge of achieving a "grand bargain" in which fair prices and fair access provide optimal benefits to both patients [...]
PRESS RELEASE: Arthritis Foundation and IVI Release Paper
Arthritis Foundation and Innovation and Value Initiative Release Paper Highlighting Patient Perspectives in Rheumatoid Arthritis Alexandria, VA — November 1, 2021 — The Arthritis Foundation and the Innovation and Value Initiative (IVI) have partnered [...]
IVI’s Rick Chapman Reacts to CMMI’s Strategic Refresh
IVI's Chief Science Officer, Rick Chapman, spoke with AJMC after CMMI’s webinar to discuss their strategic refresh and IVI’s principles for value assessment. Read the full article on AJMC here. The Innovation and Value [...]
The US Should Change Payment To Make Health Care More Equitable
The Health Affairs series continues with a post by Amol Navathe, Risa Lavizzo-Mourey and Joshua Laio examining how fee for service and risk-based payments fuel inequities and four ways we can set an explicit intention [...]
How COVID Can Help Us Refocus On The How And Why Of Value Assessment
Our second post in the Health Affairs blog series explores how value assessment can bridge the gap between healthcare consumption and payment decisions. Mark Linthicum, Darius Lakdawalla, and Chuck Phelps discuss emerging methods to [...]
The Future Of Value Assessment In A Post-Pandemic United States
We begin our Health Affairs blog series with the Global Liver Institute’s Donna Cryer sharing insights on how the pandemic has altered our views about how we measure value and how it influences access [...]
Value Must Be Inclusive
Author: Rick Chapman, PhD, Chief Science Officer In the context of value assessment, what does patient representativeness mean? A new infographic from IVI, "Value assessment should serve diverse populations and the organizations that provide [...]
IVI/PAVE Research to be Presented at SMDM Annual Meeting
Results Will Inform IVI's Major Depressive Disorder Model Professor Susan dosReis, PhD and Associate Professor Julia Slejko, PhD of the Center for Patient Driven Values in Healthcare Evaluation (PAVE), University of Maryland School of [...]
PRESS RELEASE: IVI Opens Registration for Methods Summit to Drive Patient-Centered Value Assessment
National Quality Forum's Dana Gelb Safran will Keynote October 27th Event Alexandria, VA — September 30, 2021 — The Innovation and Value Initiative (IVI), an independent, nonprofit research organization dedicated to advancing patient-centric value assessment, today opened registration [...]
IVI MEMBER SPOTLIGHT: The Assistance Fund
Over the summer, we sat down with Stephanie Marshall, Director of Advocacy from The Assistance Fund to learn more about the organization and their priorities for the future of value assessment. [...]
In Memoriam: Samuel Nussbaum, MD
The staff and volunteer leaders of the Innovation and Value Initiative (IVI) mourn the passing of Samuel Nussbaum, MD, on September 23, 2021. Dr. Nussbaum chaired the IVI Board of Directors since 2019 and was [...]